Marc Ballas is an Oncology physician affiliated with GlaxoSmithKline. OpenAlex indexes 184 publications with 1,366 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
160 E 34th St
Rm 820
New York, NY 100164744
Telephone
212-731-6645Registry record last updated 25 Jul 2011.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors
Journal for ImmunoTherapy of Cancer
2025 - INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors
Cancer Immunology Immunotherapy
2024 - Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Cancer Research Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Anil Panackal, MD, SM, FACP
GlaxoSmithKline
Paul Jones
GlaxoSmithKline
Laurence Collette
GlaxoSmithKline
Peter Hugo Howarth
GlaxoSmithKline
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”